0.65 USD
▲+0.00+0.74%
盘后 0.85 0.00%
2026-09-16
市值
$2.62M
市盈率
—
EPS
-17.16
股息率
—
52 周区间
0.59 – 209.50
成交量
112.33K
Beta
2.67
目标价
—
52W 低 0.5952W 高 209.50
价格走势
公司简介
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men’s health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test. The company was formerly known as Bl...